Faculty of Social Sciences, Charles University, Opletalova 26, 110 00 Prague, Czech Republic.
University Hospital Ostrava - Medical Faculty of Ostrava University, Department of Neurology, Ostrava, Czech Republic; Executive Board of Czech Stroke Society, Czech Neurological Society of the J. E. Purkyně Czech Medical Society, Prague, Czech Republic.
Health Policy. 2021 Apr;125(4):520-525. doi: 10.1016/j.healthpol.2021.01.011. Epub 2021 Jan 30.
This article describes policy processes that have led to the re-organisation of stroke care in the Czech Republic since 2011, which has been part of a broader process of care concentration in several medical fields. Currently, stroke care is provided by 13 Comprehensive and 32 Primary Stroke Centres. The paper explains factors that supported the reform implementation, reviews implications, and discusses future challenges. Mandatory reporting of quality indicators, the introduction of a benchmarking system, integration with pre-hospital emergency care, and the introduction of countrywide patient triage have supported more timely treatment for stroke patients and better quality of care. Data from the Stroke Care Quality Indicators of the Czech Stroke Society show positive trends in many areas: the number of patients treated with intravenous thrombolysis quadrupled in eight years, with 26.4 % of all acute stroke patients receiving thrombolysis in 2018. Czech Republic now ranks third in Europe in the number of thrombolysis per population and second in the number of mechanical thrombectomies per population. The Czech experience provides an example of positive outcomes of concentrated stroke care, while highlighting the importance of proper implementation processes. In particular, it is essential to involve stakeholders and to provide reputational incentives through continuous benchmarking.
本文描述了自 2011 年以来导致捷克共和国重新组织卒中护理的政策过程,这是在几个医疗领域集中护理过程的一部分。目前,卒中护理由 13 个综合卒中中心和 32 个初级卒中中心提供。本文解释了支持改革实施的因素,回顾了其影响,并讨论了未来的挑战。强制性报告质量指标、引入基准测试系统、与院前急救相结合以及引入全国性患者分诊,支持了卒中患者更及时的治疗和更好的护理质量。捷克卒中学会的卒中护理质量指标数据显示,许多领域都出现了积极的趋势:八年内接受静脉溶栓治疗的患者数量增加了四倍,2018 年所有急性卒中患者中有 26.4%接受了溶栓治疗。捷克共和国现在在欧洲溶栓治疗的人口数量排名第三,在机械取栓治疗的人口数量排名第二。捷克的经验为集中的卒中护理提供了积极成果的范例,同时强调了适当实施过程的重要性。特别是,通过持续的基准测试,必须让利益相关者参与并提供声誉激励。